(Circulation. 1999;99:331-333.)
© 1999 American Heart Association, Inc.
Editorial |
From the Human Genetics Center (E.B., M.F.) and Institute of Molecular Medicine (E.B., P.A.D., M.F.), The University of TexasHouston Health Science Center.
Correspondence to Eric Boerwinkle, PhD, Human Genetics Center, The University of TexasHouston Health Science Center, PO Box 20334, Houston, TX 77225. E-mail eboerwin@gsbs.gs.uth.tmc.edu
Key Words: Editorials stroke genetics
Stroke is the single
leading cause of severe disability and the third leading cause of death
in the United States.1 A large number of studies have
evaluated the prevalence of stroke in various populations, and these
studies have identified sex, age, race, uncontrolled hypertension,
diabetes, cigarette smoking, and family history as significant risk
factors. Of the
250 000 deaths each year due to the complications
of untreated hypertension, one third are due to stroke, and blood
pressure control is known to reduce the risk of stroke and stroke
mortality.2 However, these risk factors play different
roles in the 2 major stroke types, hemorrhagic and
infarctive,3 infarctive being the more common type in the
United States.
Twin and family studies have determined that there is a significant familial or genetic component underlying the occurrence of stroke. Analysis of twin pairs from the registry maintained by the National Academy of Sciences yielded proband concordance rates of 17.7% for monozygotic twins and 3.6% for dizygotic twins.4 Likewise, a large number of studies have indicated that a positive family history is a significant risk factor for future stroke among offspring.5 As is the case with other complex diseases, studies of the genetics of stroke need to move from arguing that genes are involved in the pathogenesis and risk of stroke toward identifying and characterizing the specific genes contributing to disease risk.
Some successes have been realized for mendelian disorders
associated with stroke. For example, mutations in the human Notch
3 gene on chromosome 19p13
This article has been cited by other articles:
![]() |
B. Voetsch, K. S. Benke, B. P. Damasceno, L. H. Siqueira, and J. Loscalzo Paraoxonase 192 Gln->Arg Polymorphism: An Independent Risk Factor for Nonfatal Arterial Ischemic Stroke Among Young Adults Stroke, June 1, 2002; 33(6): 1459 - 1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hassan, P. C. Sham, and H. S. Markus Planning genetic studies in human stroke: Sample size estimates based on family history data Neurology, May 28, 2002; 58(10): 1483 - 1488. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |